Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services (NY: WST )

321.70 +5.12 (+1.62%)
Streaming Delayed Price Updated: 1:50 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services

< Previous 1 2 3 4 5 6 7 8 Next >
Recap: West Pharmaceutical Q3 Earnings
West Pharmaceutical Servs (NYSE:WST) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 838 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 456 stocks hit new 52-week lows. 
Via Benzinga
West Pharmaceutical Services Shares Slides Post Q1 Results
Via Benzinga
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million. 
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
Here's How Much $1000 Invested In West Pharmaceutical Servs 10 Years Ago Would Be Worth Today
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 10 years by 18.96% on an annualized basis producing an average annual return of 30.3%. Currently, West Pharmaceutical... 
Via Benzinga
West Pharmaceutical Servs's Return On Capital Employed Insights
According to Benzinga Pro, during Q2, West Pharmaceutical Servs (NYSE:WST) earned $188.50 million, a 8.46% increase from the preceding quarter. West Pharmaceutical Servs also posted a total of $771.30... 
Via Benzinga
West Pharmaceutical Services: Q2 Earnings Insights
  West Pharmaceutical Servs (NYSE:WST) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
West Pharmaceutical Servs: Q1 Earnings Insights
West Pharmaceutical Servs (NYSE:WST) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Becton Dickinson Stock Near High, Hits 80-Plus RS Rating
Becton Dickinson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82. 
Via Investor's Business Daily
19 Dividend Stocks That Pay In February, May, August And November
Looking to fill in your dividend calendar? These top dividend stocks pay quarterly. 
Via Talk Markets
Earnings Scheduled For July 28, 2022
Companies Reporting Before The Bell • ArcelorMittal (NYSE:MT) is estimated to report earnings for its second quarter. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 435 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion. 
Via Benzinga
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
Ominous Death Cross Forms On West Pharmaceutical Servs's Chart
If history is any guide, there may be trouble ahead for shares of West Pharmaceutical Servs (NYSE:WST). A so-called "death cross" has formed on its chart and, not surprisingly,... 
Via Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
West Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8%
West Pharmaceutical Services Inc's (NYSE: WST) Q4 net s 
Via Benzinga
West Pharmaceutical Servs: Q4 Earnings Insights
  West Pharmaceutical Servs (NYSE:WST) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks. 
Via Talk Markets
West Pharmaceutical Servs's Ex-Dividend Date Is Monday, Here's What You Need To Know
Monday marks the last chance for investors to receive the next dividend payout from West Pharmaceutical Servs. What's Happening 
Via Benzinga
Microsoft, Google Lead 5 Long-Term Leaders Near Buy Points
Microsoft has formed a flat base amid solid growth. Google is actionable now. 
Via Investor's Business Daily
$1000 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.76% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could... 
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.12% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could... 
Via Benzinga
When Winning Streaks Stop: Trying To Beat The Market By Buying Stocks Like Tesla
Teslas getting charged in a Wawa parking lot last month. Photo via author. When Winning Streaks Stop In a post in August (Tesla And The Quest For Alpha), we wrote about how a... 
Via Benzinga
When Winning Streaks Stop
Trying to beat the market by buying stocks like Tesla. It's probably impossible to time these things perfectly, but as we continue to collect data, we may be able to spend more time in winning... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.